{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:38:57Z","timestamp":1787647137854,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P50-CA140146"],"award-info":[{"award-number":["P50-CA140146"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41379-021-00855-1","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T09:04:09Z","timestamp":1623747849000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8155-7131","authenticated-orcid":false,"given":"Jennifer A.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3218-1075","authenticated-orcid":false,"given":"Zehra","family":"Ordulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankhuri","family":"Wanjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-8205","authenticated-orcid":false,"given":"Cristina R.","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren L.","family":"Ritterhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00855-1_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200201000-00001","article-title":"Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors","volume":"26","author":"Vang","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PAS.0000000000000133","article-title":"Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases","volume":"38","author":"Schoolmeester","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","article-title":"Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors","volume":"42","author":"Bennett","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/PAS.0000000000001572","article-title":"Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation","volume":"45","author":"Selenica","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib5","doi-asserted-by":"crossref","unstructured":"Bennett, JA & Oliva, E Perivascular epithelioid cell tumors (PEComa) of the gynecologic tract. Genes Chromosomes Cancer. 2020;60:168-179. https:\/\/doi.org\/10.1002\/gcc.22908.","DOI":"10.1002\/gcc.22908"},{"key":"10.1038\/s41379-021-00855-1_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000478-200402000-00013","article-title":"Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa","volume":"28","author":"Silva","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.anndiagpath.2004.10.011","article-title":"A uterine leiomyosarcoma that became positive for HMB45 in the metastasis","volume":"9","author":"Silva","year":"2005","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.pas.0000213346.57391.70","article-title":"HMB-45 reactivity in conventional uterine leiomyosarcomas","volume":"31","author":"Simpson","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib9","doi-asserted-by":"crossref","unstructured":"Valencia-Guerrero, A, Pinto, A, Anderson, WJ, Trevisan, G, Nucci, MR & Hirsch, MS. PNL2: A useful adjunct biomarker to HMB45 in the diagnosis of uterine perivascular epithelioid cell tumor (PEComa). Int J Gynecol Pathol. 2020;39:529-536. https:\/\/doi.org\/10.1097\/PGP.0000000000000653.","DOI":"10.1097\/PGP.0000000000000653"},{"key":"10.1038\/s41379-021-00855-1_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays","volume":"19","author":"Kadri","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1038\/s41379-021-00855-1_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41379-019-0375-9","article-title":"Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases","volume":"33","author":"Bennett","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib12","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41379-019-0298-5","article-title":"Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia\/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma","volume":"32","author":"Chapel","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib13","unstructured":"WHO classification of tumours female genital tumors. (World Health Organization: Lyon, 2020)."},{"key":"10.1038\/s41379-021-00855-1_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/106689690000800411","article-title":"Hyalinized uterine mesenchymal neoplasms with HMB-45-positive epithelioid cells: epithelioid leiomyomas or angiomyolipomas? report of four cases","volume":"8","author":"Michal","year":"2000","journal-title":"Int J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/106689690100900415","article-title":"HMB45+ hyalinized epithelioid tumor of the uterus is linked to epithelioid leiomyoma rather than to PEC-omas","volume":"9","author":"Zamecnik","year":"2001","journal-title":"Int J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2559.2005.02147.x","article-title":"Uterine leiomyosarcoma with HMB45+ clear cell areas: report of two cases","volume":"47","author":"Hurrell","year":"2005","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00855-1_bib17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/modpathol.2009.58","article-title":"Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas","volume":"22","author":"Martignoni","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A distinctive subset of PEComas harbors TFE3 gene fusions","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAS.0000000000000349","article-title":"TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis","volume":"39","author":"Schoolmeester","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1159\/000510241","article-title":"Characterization of clinical cases of malignant PEComa via comprehensive genomic profiling of DNA and RNA","volume":"98","author":"Akumalla","year":"2020","journal-title":"Oncology"},{"key":"10.1038\/s41379-021-00855-1_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cjp2.187","article-title":"TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms","volume":"7","author":"Schmiester","year":"2021","journal-title":"J Pathol Clin Res"},{"key":"10.1038\/s41379-021-00855-1_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1200\/JCO.2009.25.2981","article-title":"Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors","volume":"28","author":"Wagner","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00855-1_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","article-title":"Dichotomy of genetic abnormalities in PEComas with therapeutic implications","volume":"39","author":"Agaram","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib24","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-19-3959","article-title":"Genomic landscape of uterine sarcomas defined through prospective clinical sequencing","volume":"26","author":"Hensley","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00855-1_bib25","doi-asserted-by":"crossref","first-page":"e1005850","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"Makinen","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1038\/s41379-021-00855-1_bib26","first-page":"276A","article-title":"Leiomyoma with bizarre nuclei: correlation between morphology and fumarate hydratase\/S-(2-Succino)-cysteine expression","volume":"28","author":"Bennett","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00855-1_bib28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Electronic address, e. d. s. c. & cancer genome atlas research, N. comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","author":"Cancer Genome Atlas Research Network.","year":"2017","journal-title":"Cell"},{"key":"10.1038\/s41379-021-00855-1_bib29","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1158\/1078-0432.CCR-19-0288","article-title":"Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas)","volume":"25","author":"Sanfilippo","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00855-1_bib30","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1158\/1078-0432.CCR-20-1191","article-title":"Addition of antiestrogen treatment in patients with malignant PEComa progressing to mTOR inhibitors","volume":"26","author":"Sanfilippo","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00855-1_bib31","doi-asserted-by":"crossref","first-page":"11005","DOI":"10.1200\/JCO.2019.37.15_suppl.11005","article-title":"ABI-009 (nab-sirolimus) in advanced malignant perivascular epithelioid cell tumors (PEComa): Preliminary efficacy, safety, and mutational status from AMPECT, an open label phase II registration trial","volume":"37","author":"Wagner","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00855-1_bib32","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.1200\/JCO.2020.38.15_suppl.11516","article-title":"Long\u2010term follow\u2010up for duration of response (DoR) after weekly nab\u2010sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): results from a registrational open\u2010label phase II trial, AMPECT","volume":"38","author":"Wagner","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00855-1_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00855-1_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/path.4315","article-title":"Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy","volume":"232","author":"Wu","year":"2014","journal-title":"J Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41379-018-0007-9","article-title":"TERT promoter mutation in adult granulosa cell tumor of the ovary","volume":"31","author":"Pilsworth","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/1541-7786.MCR-18-0359","article-title":"Mutational landscape of ovarian adult granulosa cell tumors from whole exome and targeted TERT promoter sequencing","volume":"17","author":"Alexiadis","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1038\/s41379-021-00855-1_bib37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41379-020-0514-3","article-title":"Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary","volume":"33","author":"Da Cruz Paula","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2014.93","article-title":"Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation","volume":"28","author":"Huang","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41379-019-0202-3","article-title":"Characteristics of mismatch repair deficiency in sarcomas","volume":"32","author":"Doyle","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00855-1_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00855-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00855-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00855-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:30:21Z","timestamp":1760229021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222002964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0893395222002964"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00855-1","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00855-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}